Clinical characteristics and comparison of study patients between CPVI and CPVI + SVC-L
| . | All patients . | HRV-analysed patients . | ||||
|---|---|---|---|---|---|---|
| CPVI (n = 100) . | CPVI + SVC-L (n = 100) . | P-value . | CPVI (n = 28) . | CPVI + SVC-L (n = 31) . | P-value . | |
| Age (years) | 55.65 ± 11.87 | 57.89 ± 11.46 | 0.176 | 55.36 ± 9.80 | 56.35 ± 15.36 | 0.765 |
| Male (%) | 74.00 | 75.00 | 0.871 | 71.43 | 70.97 | 0.969 |
| LA size (mm) | 39.53 ± 6.22 | 40.09 ± 5.69 | 0.505 | 39.00 ± 5.82 | 40.10 ± 5.20 | 0.448 |
| LA volume index (mL/m2) | 30.43 ± 10.06 | 31.55 ± 11.16 | 0.473 | 28.97 ± 6.77 | 29.98 ± 9.40 | 0.641 |
| Ejection fraction (%) | 63.37 ± 9.89 | 64.60 ± 9.38 | 0.369 | 63.71 ± 10.63 | 67.06 ± 7.33 | 0.170 |
| E/E′ | 9.35 ± 3.29 | 10.69 ± 6.82 | 0.090 | 10.10 ± 3.65 | 9.84 ± 4.11 | 0.801 |
| CHADS2 score | 0.67 ± 0.92 | 0.98 ± 1.08 | 0.030* | 0.57 ± 0.69 | 1.13 ± 1.06 | 0.019* |
| Heart failure (%) | 3.00 | 3.00 | >0.999 | 3.57 | 3.23 | >0.999 |
| Hypertension (%) | 41.00 | 53.00 | 0.089 | 42.86 | 61.29 | 0.157 |
| Age >75 years (%) | 0 | 8.00 | 0.007* | 0 | 9.68 | 0.239 |
| Diabetes mellitus (%) | 11.00 | 17.00 | 0.221 | 10.71 | 25.81 | 0.137 |
| Stroke (%) | 5.00 | 7.00 | 0.552 | 0.00 | 3.23 | >0.999 |
| TIA (%) | 1.00 | 2.00 | >0.999 | 0.00 | 3.23 | >0.999 |
| . | All patients . | HRV-analysed patients . | ||||
|---|---|---|---|---|---|---|
| CPVI (n = 100) . | CPVI + SVC-L (n = 100) . | P-value . | CPVI (n = 28) . | CPVI + SVC-L (n = 31) . | P-value . | |
| Age (years) | 55.65 ± 11.87 | 57.89 ± 11.46 | 0.176 | 55.36 ± 9.80 | 56.35 ± 15.36 | 0.765 |
| Male (%) | 74.00 | 75.00 | 0.871 | 71.43 | 70.97 | 0.969 |
| LA size (mm) | 39.53 ± 6.22 | 40.09 ± 5.69 | 0.505 | 39.00 ± 5.82 | 40.10 ± 5.20 | 0.448 |
| LA volume index (mL/m2) | 30.43 ± 10.06 | 31.55 ± 11.16 | 0.473 | 28.97 ± 6.77 | 29.98 ± 9.40 | 0.641 |
| Ejection fraction (%) | 63.37 ± 9.89 | 64.60 ± 9.38 | 0.369 | 63.71 ± 10.63 | 67.06 ± 7.33 | 0.170 |
| E/E′ | 9.35 ± 3.29 | 10.69 ± 6.82 | 0.090 | 10.10 ± 3.65 | 9.84 ± 4.11 | 0.801 |
| CHADS2 score | 0.67 ± 0.92 | 0.98 ± 1.08 | 0.030* | 0.57 ± 0.69 | 1.13 ± 1.06 | 0.019* |
| Heart failure (%) | 3.00 | 3.00 | >0.999 | 3.57 | 3.23 | >0.999 |
| Hypertension (%) | 41.00 | 53.00 | 0.089 | 42.86 | 61.29 | 0.157 |
| Age >75 years (%) | 0 | 8.00 | 0.007* | 0 | 9.68 | 0.239 |
| Diabetes mellitus (%) | 11.00 | 17.00 | 0.221 | 10.71 | 25.81 | 0.137 |
| Stroke (%) | 5.00 | 7.00 | 0.552 | 0.00 | 3.23 | >0.999 |
| TIA (%) | 1.00 | 2.00 | >0.999 | 0.00 | 3.23 | >0.999 |
Values are given as mean ± SD for continuous variables and percentages for categorical variables.
*Statistically significant.
LA, left atrium; TIA, transient ischaemic attack.
Clinical characteristics and comparison of study patients between CPVI and CPVI + SVC-L
| . | All patients . | HRV-analysed patients . | ||||
|---|---|---|---|---|---|---|
| CPVI (n = 100) . | CPVI + SVC-L (n = 100) . | P-value . | CPVI (n = 28) . | CPVI + SVC-L (n = 31) . | P-value . | |
| Age (years) | 55.65 ± 11.87 | 57.89 ± 11.46 | 0.176 | 55.36 ± 9.80 | 56.35 ± 15.36 | 0.765 |
| Male (%) | 74.00 | 75.00 | 0.871 | 71.43 | 70.97 | 0.969 |
| LA size (mm) | 39.53 ± 6.22 | 40.09 ± 5.69 | 0.505 | 39.00 ± 5.82 | 40.10 ± 5.20 | 0.448 |
| LA volume index (mL/m2) | 30.43 ± 10.06 | 31.55 ± 11.16 | 0.473 | 28.97 ± 6.77 | 29.98 ± 9.40 | 0.641 |
| Ejection fraction (%) | 63.37 ± 9.89 | 64.60 ± 9.38 | 0.369 | 63.71 ± 10.63 | 67.06 ± 7.33 | 0.170 |
| E/E′ | 9.35 ± 3.29 | 10.69 ± 6.82 | 0.090 | 10.10 ± 3.65 | 9.84 ± 4.11 | 0.801 |
| CHADS2 score | 0.67 ± 0.92 | 0.98 ± 1.08 | 0.030* | 0.57 ± 0.69 | 1.13 ± 1.06 | 0.019* |
| Heart failure (%) | 3.00 | 3.00 | >0.999 | 3.57 | 3.23 | >0.999 |
| Hypertension (%) | 41.00 | 53.00 | 0.089 | 42.86 | 61.29 | 0.157 |
| Age >75 years (%) | 0 | 8.00 | 0.007* | 0 | 9.68 | 0.239 |
| Diabetes mellitus (%) | 11.00 | 17.00 | 0.221 | 10.71 | 25.81 | 0.137 |
| Stroke (%) | 5.00 | 7.00 | 0.552 | 0.00 | 3.23 | >0.999 |
| TIA (%) | 1.00 | 2.00 | >0.999 | 0.00 | 3.23 | >0.999 |
| . | All patients . | HRV-analysed patients . | ||||
|---|---|---|---|---|---|---|
| CPVI (n = 100) . | CPVI + SVC-L (n = 100) . | P-value . | CPVI (n = 28) . | CPVI + SVC-L (n = 31) . | P-value . | |
| Age (years) | 55.65 ± 11.87 | 57.89 ± 11.46 | 0.176 | 55.36 ± 9.80 | 56.35 ± 15.36 | 0.765 |
| Male (%) | 74.00 | 75.00 | 0.871 | 71.43 | 70.97 | 0.969 |
| LA size (mm) | 39.53 ± 6.22 | 40.09 ± 5.69 | 0.505 | 39.00 ± 5.82 | 40.10 ± 5.20 | 0.448 |
| LA volume index (mL/m2) | 30.43 ± 10.06 | 31.55 ± 11.16 | 0.473 | 28.97 ± 6.77 | 29.98 ± 9.40 | 0.641 |
| Ejection fraction (%) | 63.37 ± 9.89 | 64.60 ± 9.38 | 0.369 | 63.71 ± 10.63 | 67.06 ± 7.33 | 0.170 |
| E/E′ | 9.35 ± 3.29 | 10.69 ± 6.82 | 0.090 | 10.10 ± 3.65 | 9.84 ± 4.11 | 0.801 |
| CHADS2 score | 0.67 ± 0.92 | 0.98 ± 1.08 | 0.030* | 0.57 ± 0.69 | 1.13 ± 1.06 | 0.019* |
| Heart failure (%) | 3.00 | 3.00 | >0.999 | 3.57 | 3.23 | >0.999 |
| Hypertension (%) | 41.00 | 53.00 | 0.089 | 42.86 | 61.29 | 0.157 |
| Age >75 years (%) | 0 | 8.00 | 0.007* | 0 | 9.68 | 0.239 |
| Diabetes mellitus (%) | 11.00 | 17.00 | 0.221 | 10.71 | 25.81 | 0.137 |
| Stroke (%) | 5.00 | 7.00 | 0.552 | 0.00 | 3.23 | >0.999 |
| TIA (%) | 1.00 | 2.00 | >0.999 | 0.00 | 3.23 | >0.999 |
Values are given as mean ± SD for continuous variables and percentages for categorical variables.
*Statistically significant.
LA, left atrium; TIA, transient ischaemic attack.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
